Menu
Search
|

Menu

Close
X

Midatech Pharma PLC MTP.OQ (NASDAQ Stock Exchange Capital Market)

0.35 USD
-0.03 (-7.89%)
As of Nov 16
chart
Previous Close 0.38
Open 0.38
Volume 16,623
3m Avg Volume 6,059
Today’s High 0.38
Today’s Low 0.34
52 Week High 2.65
52 Week Low 0.34
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
29.34
Price to Sales (TTM)
vs sector
--
20.58
Price to Book (MRQ)
vs sector
--
4.23
Price to Cash Flow (TTM)
vs sector
--
21.19
Total Debt to Equity (MRQ)
vs sector
--
13.84
LT Debt to Equity (MRQ)
vs sector
--
9.93
Return on Investment (TTM)
vs sector
--
13.58
Return on Equity (TTM)
vs sector
--
15.11

EXECUTIVE LEADERSHIP

Rolf Stahel
Non-Executive Chairman of the Board, Since
Salary: £175,967.00
Bonus: --
Craig Cook
Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Nicholas Robbins-Cherry
Finance Director, Director, Since
Salary: £9,821.00
Bonus: £40,755.00
Daniel Palmer
Chief Scientific Officer, Since
Salary: --
Bonus: --
Justin Barry
Head - Manufacturing, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

65 Innovation Drive, Milton Park
ABINGDON     OX14 4RQ

Phone: +441235.841575

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.

SPONSORED STORIES